...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: is any one going tmr? Questions?

Tada brought up these 2 

"I hope someone asks the question at the AGM ; are there still patients from the PI mCRPC trial 1) still alive and 2) still taking ZEN-3694."

my question is :

When can we expect a Liquidity event?

Can we just forward these on to IR or is someone planing on asking these & other questions?

TIA

 

just sent a mail to Chris seeing if i can foward these 3 to him for possible review & answers tmr.

Share
New Message
Please login to post a reply